BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Qfitlia (Fitusiran) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Qfitlia (Fitusiran)\, from ClinicalTrials
 .gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05662319-10760@assetmemo.bio
DTSTAMP:20261121T004941Z
DTSTART;VALUE=DATE:20270325
DTEND;VALUE=DATE:20270326
SUMMARY:Qfitlia (Fitusiran): Phase 3 readout est. (NCT05662319)
DESCRIPTION:Qfitlia (Fitusiran)\, phase 3.\nStudy: A Study to Test a Medici
 ne (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in
  Male Adolescent or Adult Participants With Severe Hemophilia\nEstimated p
 rimary completion: 25 March 2027. This is a ClinicalTrials.gov estimate\, 
 not a confirmed readout date\, and it can move.\nDrug page: https://assetm
 emo.bio/drug/fitusiran#upcoming-events\nRegistry record: https://clinicalt
 rials.gov/study/NCT05662319
URL:https://assetmemo.bio/drug/fitusiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06145373-10760@assetmemo.bio
DTSTAMP:20261121T004941Z
DTSTART;VALUE=DATE:20280528
DTEND;VALUE=DATE:20280529
SUMMARY:Qfitlia (Fitusiran): Phase 4 readout est. (NCT06145373)
DESCRIPTION:Qfitlia (Fitusiran)\, phase 4.\nStudy: A Study to Test a Medici
 ne (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who 
 Previously Received Preventive Treatment With Emicizumab\nEstimated primar
 y completion: 28 May 2028. This is a ClinicalTrials.gov estimate\, not a c
 onfirmed readout date\, and it can move.\nDrug page: https://assetmemo.bio
 /drug/fitusiran#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT06145373
URL:https://assetmemo.bio/drug/fitusiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07285460-10760@assetmemo.bio
DTSTAMP:20261121T004941Z
DTSTART;VALUE=DATE:20290804
DTEND;VALUE=DATE:20290805
SUMMARY:Qfitlia (Fitusiran): Phase 3 readout est. (NCT07285460)
DESCRIPTION:Qfitlia (Fitusiran)\, phase 3.\nStudy: A Study to Investigate t
 he Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 
 1 to Less Than 12 Years With Hemophilia A or B\nEstimated primary completi
 on: 4 August 2029. This is a ClinicalTrials.gov estimate\, not a confirmed
  readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/fi
 tusiran#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT07285460
URL:https://assetmemo.bio/drug/fitusiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
